Sexually transmitted infections and sexual function in relation to male fertility

Korean Journal of Urology

Volumn 54, Issue 3, 2013, Pages 149-156

  Brookings, Claire ^a   Goldmeier, David ^a   Sadeghi Nejad, Hossein ^b,c  

^a ST MARY S HOSPITAL   (United Kingdom)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Fertility; Male accessory gland infections; Men; Sexual function; Sexually transmitted infections

Indexed keywords

ALPHA GLUCOSIDASE; ANTIRETROVIRUS AGENT; CITRIC ACID; DOXYCYCLINE; IMMUNOGLOBULIN G; METRONIDAZOLE; NITROFURANTOIN; PHENYTOIN; SALAZOSULFAPYRIDINE; SPIRONOLACTONE; STEROID; TESTOSTERONE; TRIPTERYGIUM WILFORDII EXTRACT; VALACICLOVIR;

CD4 LYMPHOCYTE COUNT; CHEMOTHERAPY; CHLAMYDIA TRACHOMATIS; CHRONIC INFLAMMATION; DISEASE ASSOCIATION; ECHOGRAPHY; EPIDIDYMITIS; ERECTILE DYSFUNCTION; GENITAL TRACT INFECTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAUTERINE INSEMINATION; MALE ACCESSORY GLAND INFECTION; MALE FERTILITY; MYCOPLASMA GENITALIUM; NEISSERIA GONORRHOEAE; NONHUMAN; ORCHITIS; POLYMERASE CHAIN REACTION; PREVALENCE; PROSTATITIS; PSYCHOLOGICAL ASPECT; REVIEW; SEXUALLY TRANSMITTED DISEASE; SPERMATOZOON MOTILITY; SYPHILIS; TRICHOMONIASIS; UREAPLASMA UREALYTICUM; URETHRITIS; VIRUS INFECTION;

EID: 84875320296     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2013.54.3.149     Document Type: Review

References (71)

1. UNAIDS. UNAIDS world AIDS day report 2011 [Internet]. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS); [cited 2013 Jan 30]. Available from: http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2011/JC2216_WorldAIDSday_report_2011_en.pdf.
2. World Health Organization (WHO). Sexually transmitted infections Fact sheet N°110 August 2011 [Internet]. Geneva: WHO; c2013 [cited 2013 Jan 16]. Available from: http://www.who.int/mediacentre/factsheets/fs110/en/.
3. World Health Organization (WHO). Infertility: a tabulation of available data on prevalence of primary and secondary infertility. WHO/MCH/91.9 [Internet]. Geneva: WHO, Division of Family Health, Programme on Maternal and Child Health and Family Planning; c2013 [cited 2013 Jan 16]. Available from: http://whqlibdoc.who.int/hq/1991/WHO_MCH_91.9.pdf.
4. Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S, Stevens GA. National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLoS Med 2012;9:e1001356.
5. Comhaire FH, Rowe PJ, Farley TM. The effect of doxycycline in infertile couples with male accessory gland infection: a double blind prospective study. Int J Androl 1986;9:91-8.
6. Christiansen E, Tollefsrud A, Purvis K. Sperm quality in men with chronic abacterial prostatovesiculitis verified by rectal ultrasonography. Urology 1991;38:545-9.
7. Giamarellou H, Tympanidis K, Bitos NA, Leonidas E, Daikos GK. Infertility and chronic prostatitis. Andrologia 1984;16:417-22.
8. Mazzoli S, Cai T, Addonisio P, Bechi A, Mondaini N, Bartoletti R. Chlamydia trachomatis infection is related to poor semen quality in young prostatitis patients. Eur Urol 2010;57:708-14.
9. Rybar R, Prinosilova P, Kopecka V, Hlavicova J, Veznik Z, Zajicova A, et al. The effect of bacterial contamination of semen on sperm chromatin integrity and standard semen parameters in men from infertile couples. Andrologia 2012;44 Suppl 1:410-8.
10. Carne CA, Chilcott S, Palmer C, Green O, Bridge S, Walsh R, et al. Low sperm counts in genitourinary medicine clinic attendees: results from a case-control study. Sex Transm Infect 2012;88: 422-6.
11. Gunyeli I, Abike F, Dunder I, Aslan C, Tapi{dotless}si{dotless}z OL, Temizkan O, et al. Chlamydia, Mycoplasma and Ureaplasma infections in infertile couples and effects of these infections on fertility. Arch Gynecol Obstet 2011;283:379-85.
12. Cengiz T, Aydoganli L, Baykam M, Mungan NA, Tuncbilek E, Dincer M, et al. Chlamydial infections and male infertility. Int Urol Nephrol 1997;29:687-93.
13. Gallegos G, Ramos B, Santiso R, Goyanes V, Gosalvez J, Fernandez JL. Sperm DNA fragmentation in infertile men with genitourinary infection by Chlamydia trachomatis and Mycoplasma. Fertil Steril 2008;90:328-34.
14. Gdoura R, Keskes-Ammar L, Bouzid F, Eb F, Hammami A, Orfila J. Chlamydia trachomatis and male infertility in Tunisia. Eur J Contracept Reprod Health Care 2001;6:102-7.
15. Kokab A, Akhondi MM, Sadeghi MR, Modarresi MH, Aarabi M, Jennings R, et al. Raised inflammatory markers in semen from men with asymptomatic chlamydial infection. J Androl 2010;31: 114-20.
16. Vigil P, Morales P, Tapia A, Riquelme R, Salgado AM. Chlamydia trachomatis infection in male partners of infertile couples: incidence and sperm function. Andrologia 2002;34:155-61.
17. Joki-Korpela P, Sahrakorpi N, Halttunen M, Surcel HM, Paavonen J, Tiitinen A. The role of Chlamydia trachomatis infection in male infertility. Fertil Steril 2009;91(4 Suppl):1448-50.
18. Ochsendorf FR, Ozdemir K, Rabenau H, Fenner T, Oremek R, Milbradt R, et al. Chlamydia trachomatis and male infertility: chlamydia-IgA antibodies in seminal plasma are C. trachomatis specific and associated with an inflammatory response. J Eur Acad Dermatol Venereol 1999;12:143-52.
19. Hosseinzadeh S, Brewis IA, Eley A, Pacey AA. Co-incubation of human spermatozoa with Chlamydia trachomatis serovar E causes premature sperm death. Hum Reprod 2001;16:293-9.
20. World Health Organization (WHO). Initiative for vaccine research (IVR): sexually transmitted diseases [Internet]. Geneva: WHO; c2013 [cited 2013 Jan 30]. Available from http://www.who.int/vaccine_research/diseases/soa_std/en/index2.html.
21. Health Protection Agency. Health protection report (weekly report). Volume 6 Number 22 Published on: 1 June 2012 [Internet]. London: Health Protection Agency; c2013 [cited 2013 Jan 30]. Available from: http://www.hpa.org.uk/hpr/archives/2012/hpr2212.pdf.
22. Harkness AH. The pathology of gonorrhoea. Br J Vener Dis 1948;24:137-47
23. Michelson HE. Syphilis of the epididymis. JAMA 1919;73:1431-3.
24. Schiffer JT, Abu-Raddad L, Mark KE, Zhu J, Selke S, Koelle DM, et al. Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes. Proc Natl Acad Sci U S A 2010;107:18973-8.
25. Wald A, Zeh J, Selke S, Warren T, Ryncarz AJ, Ashley R, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000;342: 844-50.
26. Fleming DT, McQuillan GM, Johnson RE, Nahmias AJ, Aral SO, Lee FK, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997;337:1105-11.
27. el Borai N, Inoue M, Lefevre C, Naumova EN, Sato B, Yamamura M. Detection of herpes simplex DNA in semen and menstrual blood of individuals attending an infertility clinic. J Obstet Gynaecol Res 1997;23:17-24.
28. Bezold G, Politch JA, Kiviat NB, Kuypers JM, Wolff H, Anderson DJ. Prevalence of sexually transmissible pathogens in semen from asymptomatic male infertility patients with and without leukocytospermia. Fertil Steril 2007;87:1087-97.
29. Kapranos N, Petrakou E, Anastasiadou C, Kotronias D. Detection of herpes simplex virus, cytomegalovirus, and Epstein-Barr virus in the semen of men attending an infertility clinic. Fertil Steril 2003;79 Suppl 3:1566-70.
30. Kotronias D, Kapranos N. Detection of herpes simplex virus DNA in human spermatozoa by in situ hybridization technique. In Vivo 1998;12:391-4.
31. Bezold G, Schuster-Grusser A, Lange M, Gall H, Wolff H, Peter RU. Prevalence of human herpesvirus types 1-8 in the semen of infertility patients and correlation with semen parameters. Fertil Steril 2001;76:416-8.
32. Kundsin RB, Falk L, Hertig AT, Horne HW Jr. Acyclovir treatment of twelve unexplained infertile couples. Int J Fertil 1987;32:200-4.
33. El Borai N, LeFevre C, Inoue M, Naumova EN, Sato K, Suzuki S, et al. Presence of HSV-1 DNA in semen and menstrual blood. J Reprod Immunol 1998;41:137-47.
34. Corey L, Wald A, Patel R, Sacks SL, Tyring SK, Warren T, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004;350:11-20.
35. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, et al. Prevalence of HPV infection among females in the United States. JAMA 2007;297:813-9.
36. Lai YM, Lee JF, Huang HY, Soong YK, Yang FP, Pao CC. The effect of human papillomavirus infection on sperm cell motility. Fertil Steril 1997;67:1152-5.
37. Rintala MA, Grenman SE, Pollanen PP, Suominen JJ, Syrjanen SM. Detection of high-risk HPV DNA in semen and its association with the quality of semen. Int J STD AIDS 2004;15:740-3.
38. Tanaka H, Karube A, Kodama H, Fukuda J, Tanaka T. Mass screening for human papillomavirus type 16 infection in infertile couples. J Reprod Med 2000;45:907-11.
39. Townsend CL, Cortina-Borja M, Peckham CS, de Ruiter A, Lyall H, Tookey PA. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS 2008;22:973-81.
40. Shevchuk MM, Pigato JB, Khalife G, Armenakas NA, Fracchia JA. Changing testicular histology in AIDS: its implication for sexual transmission of HIV. Urology 1999;53:203-8.
41. Crum-Cianflone NF, Bavaro M, Hale B, Amling C, Truett A, Brandt C, et al. Erectile dysfunction and hypogonadism among men with HIV. AIDS Patient Care STDS 2007;21:9-19.
42. Crittenden JA, Handelsman DJ, Stewart GJ. Semen analysis in human immunodeficiency virus infection. Fertil Steril 1992;57: 1294-9.
43. Nicopoullos JD, Almeida PA, Ramsay JW, Gilling-Smith C. The effect of human immunodeficiency virus on sperm parameters and the outcome of intrauterine insemination following sperm washing. Hum Reprod 2004;19:2289-97.
44. Bujan L, Hollander L, Coudert M, Gilling-Smith C, Vucetich A, Guibert J, et al. Safety and efficacy of sperm washing in HIV-1-serodiscordant couples where the male is infected: results from the European CREAThE network. AIDS 2007;21:1909-14.
45. Kato S, Hanabusa H, Kaneko S, Takakuwa K, Suzuki M, Kuji N, et al. Complete removal of HIV-1 RNA and proviral DNA from semen by the swim-up method: assisted reproduction technique using spermatozoa free from HIV-1. AIDS 2006;20:967-73.
46. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 2012;367:399-410.
47. Vernazza P, Hirschel B, Bernasconi E, Flepp M. Les personnes séropositives ne souffrant d'aucune autre MST et suivant un traitment antirétroviral efficace ne transmettent pas le VIH par voie sexuelle. Bulletin des médecins suisses. Schweizerische Ärztezeitung. Bollettino dei medici svizzeri 2008;89:5. English translation [Internet]. [cited 2013 Jan 30]. Available from: http://www.edwinjbernard.com/pdfs/Swiss%20Commission%20statement_May%202008_translation%20EN.pdf.
48. National Institutes of Health. Treating HIV-infected people with antiretrovirals protects partners from infection: findings result from NIH-funded International Study [Internet]. Bethesda: National Institutes of Health; [cited 2013 Jan 30]. Available from: http://www.niaid.nih.gov/news/newsreleases/2011/Pages/HPTN052.aspx.
49. Fakoya A, Lamba H, Mackie N, Nandwani R, Brown A, Bernard E, et al. British HIV Association, BASHH and FSRH guidelines for the management of the sexual and reproductive health of people living with HIV infection 2008. HIV Med 2008;9:681-720.
50. Sutton M, Sternberg M, Koumans EH, McQuillan G, Berman S, Markowitz L. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004. Clin Infect Dis 2007;45:1319-26.
51. Tuttle JP Jr, Holbrook TW, Derrick FC. Interference of human spermatozoal motility by trichomonas vaginalis. J Urol 1977;118: 1024-5.
52. Jarecki-Black JC, Lushbaugh WB, Golosov L, Glassman AB. Trichomonas vaginalis: preliminary characterization of a sperm motility inhibiting factor. Ann Clin Lab Sci 1988;18:484-9.
53. Gopalkrishnan K, Hinduja IN, Kumar TC. Semen characteristics of asymptomatic males affected by Trichomonas vaginalis. J In Vitro Fert Embryo Transf 1990;7:165-7.
54. Daly JJ, Sherman JK, Green L, Hostetler TL. Survival of Trichomonas vaginalis in human semen. Genitourin Med 1989;65:106-8.
55. World Health Organisation (WHO). Global prevalence and incidence of selected curable sexually transmitted infections overview and estimates [Internet]. Geneva: WHO; c2013 [cited 2012 Jul 24]. Available from: http://www.who.int/hiv/pub/sti/who_hiv_aids_2001.02.pdf.
56. Health Protection Agency. Sexually transmitted infections annual data [Internet]. London: Health Protection Agency; c2013 [cited Jan 30]. Available from: http://www.hpa.org.uk/web/HPAweb&Page&HPAwebAutoListName/Page/1201094610372.
57. Centers for Disease Control and Prevention. 2010 sexually transmitted diseases surveillance [Internet]. Atlanta: Centers for Disease Control and Prevention; [cited 2013 Jan 30]. Available from: http://www.cdc.gov/std/stats10/syphilis.htm.
58. Cheng L, Bostwick DG, editors. Essentials of anatomic pathology. Totowa: Humana Press; 2002.
59. World Health Organisation (WHO). Standards for maternal and neonatal care. Prevention of mother-to-child transmission of syphilis. Integrated management of pregnancy and childbirth (IMPAC) [Internet]. Geneva: WHO; c2013 [cited Jan 30]. Available from http://www.who.int/reproductivehealth/publications/maternal_perinatal_health/prevention_mtct_syphilis.pdf.
60. Mehik A, Hellstrom P, Sarpola A, Lukkarinen O, Jarvelin MR. Fears, sexual disturbances and personality features in men with prostatitis: a population-based cross-sectional study in Finland. BJU Int 2001;88:35-8.
61. Brookes JL, Haywood S, Green J. Adjustment to the psychological and social sequelae of recurrent genital herpes simplex infection. Genitourin Med 1993;69:384-7.
62. Catotti DN, Clarke P, Catoe KE. Herpes revisited. Still a cause of concern. Sex Transm Dis 1993;20:77-80.
63. Rosenthal SL, Zimet GD, Leichliter JS, Stanberry LR, Fife KH, Tu W, et al. The psychosocial impact of serological diagnosis of asymptomatic herpes simplex virus type 2 infection. Sex Transm Infect 2006;82:154-7.
64. Carney O, Ross E, Ikkos G, Mindel A. The effect of suppressive oral acyclovir on the psychological morbidity associated with recurrent genital herpes. Genitourin Med 1993;69:457-9.
65. Conaglen HM, Hughes R, Conaglen JV, Morgan J. A prospective study of the psychological impact on patients of first diagnosis of human papillomavirus. Int J STD AIDS 2001;12:651-8.
66. Maw RD, Reitano M, Roy M. An international survey of patients with genital warts: perceptions regarding treatment and impact on lifestyle. Int J STD AIDS 1998;9:571-8.
67. Reed BD, Ruffin MT, Gorenflo DW, Zazove P. The psychosexual impact of human papillomavirus cervical infections. J Fam Pract 1999;48:110-6.
68. Clarke P, Ebel C, Catotti DN, Stewart S. The psychosocial impact of human papillomavirus infection: implications for health care providers. Int J STD AIDS 1996;7:197-200.
69. Lamba H, Goldmeier D, Mackie NE, Scullard G. Antiretroviral therapy is associated with sexual dysfunction and with increased serum oestradiol levels in men. Int J STD AIDS 2004;15:234-7.
70. Goldmeier D, Scullard G, Kapembwa M, Lamba H, Frize G. Does increased aromatase activity in adipose fibroblasts cause low sexual desire in patients with HIV lipodystrophy? Sex Transm Infect 2002;78:64-6.
71. World Health Organisation (WHO). WHO laboratory manual for the examination and processing of human semen. Fifth edition [Internet]. Geneva: WHO; c2013 [cited 2013 Jan 30]. Available from: http://whqlibdoc.who.int/publications/2010/9789241547789_eng.pdf.